Treatment of de novo bone-only oligometastatic breast cancer

被引：0
|
作者：
Fernandez, Joseff Karl [1 ]
Hui, Mun [1 ]
Harris, Georgia [2 ]
机构：
[1] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia
[2] Chris OBrien Lifehouse, Dept Radiat Oncol, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy Outcomes for Bone-Only Oligometastatic Breast Cancer
    Yilmaz, Melek Tugce
    Gultekin, Melis
    Sari, Sezin Yuce
    Kumru, Tolunay
    Kivanc, Huseyin
    Ozyigit, Gokhan
    Yildiz, Ferah
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S464 - S466
  • [2] De Novo Oligometastatic Breast Cancer
    Pusztai, Lajos
    Rozenblit, Mariya
    Dubsky, Peter
    Bachelot, Thomas
    Kirby, Anna M.
    Linderholm, Barbro K.
    White, Julia R.
    Chmura, Steven J.
    Carey, Lisa A.
    Chua, Boon H.
    Miller, Kathy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (34) : 5237 - +
  • [3] Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis
    Lin, Cheng
    Lin, Sheng
    Zhu, Lili
    Lin, Shaojun
    Pan, Jianji
    Xu, Yun
    BMC CANCER, 2022, 22 (01)
  • [4] Stereotactic Ablative Radiotherapy for Bone-Only Oligometastatic Breast Cancer: On a Quest to Find the Optimum Cohort
    Yilmaz, M. T.
    Gultekin, M.
    Sari, S. Yuce
    Kumru, T.
    Kivanc, H.
    Ozyigit, G.
    Yildiz, F.
    CLINICAL ONCOLOGY, 2025, 37
  • [5] Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis
    Cheng Lin
    Sheng Lin
    Lili Zhu
    Shaojun Lin
    Jianji Pan
    Yun Xu
    BMC Cancer, 22
  • [6] Does Locoregional Treatment in de Novo Stage IV Bone-Only Metastatic Breast Cancer Prolong Survival? An Ongoing Multicenter Registry Study
    Soran, Atilla
    Isik, Arda
    Dogan, Lutfi
    Sezgin, Efe
    Ozbas, Serdar
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E5 - E5
  • [7] Immune characterization of the de novo oligometastatic breast cancer
    Chretien, S.
    Buisseret, L.
    Wang, X.
    Rouas, G.
    Kotecki, N.
    Garaud, S.
    Mailliez, A.
    Larsimont, D.
    Rothe, F.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S75 - S75
  • [8] Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
    Ahn, Sung Gwe
    Lee, Hak Min
    Cho, Sang-Hoon
    Lee, Seung Ah
    Hwang, Seung Hyun
    Jeong, Joon
    Lee, Hy-De
    YONSEI MEDICAL JOURNAL, 2013, 54 (05) : 1168 - 1177
  • [9] ASO Author Reflections: Locoregional Therapy in De Novo Bone-Only Metastatic Breast Cancer Provides Survival Advantage Regardless of Therapy Sequencing
    Atilla Soran
    Lutfi Dogan
    Serdar Ozbas
    Annals of Surgical Oncology, 2021, 28 : 5058 - 5058
  • [10] ASO Author Reflections: Locoregional Therapy in De Novo Bone-Only Metastatic Breast Cancer Provides Survival Advantage Regardless of Therapy Sequencing
    Soran, Atilla
    Dogan, Lutfi
    Ozbas, Serdar
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 5058 - 5058
12345